Valued at a market cap of $27.5 billion, Kenvue Inc. (KVUE) is a leading consumer health company that manages some of the world’s most trusted brands, including Tylenol, Neutrogena, Listerine, Aveeno, Band-Aid, and Johnson’s Baby. The Summit, New Jersey-based company, focuses on science-backed, insight-driven “everyday care” solutions.
This household & personal products company has significantly underperformed the broader market over the past 52 weeks. Shares of Kenvue have declined 37.8% over this time frame, while the broader S&P 500 Index ($SPX) has gained 17.4%. Moreover, on a YTD basis, the stock is down 33.3%, compared to SPX’s 16% rise.
